PHI with Diabetes mellitus
How does this condition affect your private health insurance?
Zuckererkrankung, also known as Diabetes Mellitus, is a chronic metabolic disorder characterized by elevated blood glucose levels. This condition arises either from insufficient insulin production by the pancreas (Type 1 diabetes) or the body's ineffective use of the insulin it produces (Type 2 diabetes). Common symptoms include increased thirst, frequent urination, unexplained weight loss, and fatigue. If left unmanaged, diabetes can lead to severe long-term complications affecting the eyes, kidneys, nerves, and cardiovascular system. Effective management typically involves lifestyle modifications, medication, and sometimes insulin therapy to control blood sugar and prevent disease progression.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 60%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms can develop gradually over weeks to months for Type 2, or more acutely over days to weeks for Type 1, before diagnosis.
Duration of Illness (Lifetime)
Typically a chronic, lifelong condition requiring continuous management.
Cost of Treatment (Initial)
Initial diagnostic tests, doctor visits, and medication can range from several hundred to a few thousand USD.
Cost of Treatment (Lifetime)
Can range from tens of thousands to hundreds of thousands of USD over a lifetime, including medication, monitoring, and specialist care.
Mortality Rate
Significant if untreated or poorly managed, primarily due to cardiovascular complications, kidney failure, or acute metabolic crises.
Risk of Secondary Damages
High (over 70-80% without strict management) due to microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (heart attack, stroke) complications.
Probability of Full Recovery
Extremely low for Type 1; remission is possible for some Type 2 patients through significant lifestyle changes but not a 'cure'.
Underlying Disease Risk
High. Type 2 is strongly associated with obesity, hypertension, and dyslipidemia (metabolic syndrome). Type 1 is an autoimmune disease, sometimes linked to other autoimmune conditions.